Product Description
Tesamorelin is a stabilized synthetic analog of growth hormone-releasing hormone (GHRH), engineered with an N-terminal hexenoyl trans-3 modification that resists DPP-IV degradation. The result is a GHRH molecule that survives long enough to drive a clean, pulsatile release of endogenous growth hormone from the pituitary — restoring physiological GH-pulse architecture rather than the flat supraphysiological signal of exogenous rhGH.









